Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin

NCT00669695 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

OTHER

Sponsor class

Stopped Interim analysis performed without efficient results

Conditions

Obstructive Sleep Apnea Syndrome

Interventions

DRUG: Atorvastatin treatment
OTHER: CPAP device
OTHER: sham CPAP treatment

Sponsor

University Hospital, Grenoble